ACST,Acasti Pharma Inc. | Healthcare

Healthcare

ACST

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Acasti Pharma Inc.ACST

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage.

It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia.

The company was incorporated in 2002 and is headquartered in Laval, Canada.

Latest News >

--CuriosityStream Raises Quarterly Dividend to $0.03 a Share, Payable on March 28 to Shareholders of Record on March 14

Jan 31, 2025

10:09 AM EST, 01/31/2025 (MT Newswires) -- Price: 2.46, Change: +0.28, Percent Change: +13.03 ...

FAA restricting helicopter flights near Reagan National after crash

Jan 31, 2025

WASHINGTON, Jan 31 (Reuters) - The U.S. Federal Aviation Administration is indefinitely restricting helicopter flights near Washington Reagan National Airport after a deadly collision between an American Airlines ( AAL ) regional jet and Army Black Hawk killed 67 people. An FAA official on Friday told Reuters the agency was barring most helicopters from parts of two helicopter routes near...

--Civeo Maintains Quarterly Dividend at $0.25 a Share, Payable March 17 to Holders as of Feb. 24

Jan 31, 2025

10:12 AM EST, 01/31/2025 (MT Newswires) -- Price: 23.64, Change: +0.09, Percent Change: +0.38 ...

Trump says helicopter in Washington crash was flying too high

Jan 31, 2025

* Trump claims Black Hawk was flying above altitude limit * Investigation ongoing, Army urges caution and patience * Helicopter had experienced crew, recorder yet to be retrieved (Adds army official's remarks in paragraph 5, U.S. Defense Secretary Hegseth in paragraphs 6-7, details on investigation in paragraphs 11-12) By Phil Stewart, Idrees Ali and Doina Chiacu WASHINGTON, Jan 31 (Reuters)...